Bettina Meissburger

Title: Bettina Meissburger: Innovator in ROR Gamma Modulators

Introduction

Bettina Meissburger is a prominent inventor based in Eppelheim, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target the ROR gamma receptor. Her work is crucial for advancing treatments for diabetes and related disorders.

Latest Patents

Bettina holds 1 patent for her invention related to ROR gamma modulators. The patent describes compounds of formula I, or a pharmaceutically acceptable salt thereof, intended for the treatment or prevention of diseases mediated by the ROR gamma receptor. This includes specific applications for diabetes and diabetes-related disorders, especially type II diabetes. The patent also outlines methods for the production of these compounds and their application in treatment.

Career Highlights

Bettina Meissburger is affiliated with ETH Zurich, a leading research institution known for its cutting-edge scientific advancements. Her work at ETH Zurich has positioned her as a key figure in the pharmaceutical research community, contributing to innovative solutions for complex health issues.

Collaborations

Bettina has collaborated with notable colleagues, including Christian Wolfrum and Erick Moran Carreira. These partnerships have enhanced her research efforts and expanded the impact of her work in the field.

Conclusion

Bettina Meissburger's contributions to the development of ROR gamma modulators represent a significant advancement in the treatment of diabetes. Her innovative approach and collaboration with esteemed colleagues underscore her role as a leading inventor in the pharmaceutical industry.